Hepatocellular Carcinoma (HCC) Surveillance Biomarker Landscape Overview
Nov
13
2023
Product Theater 1, Exhibit Hall B
-
Hynes Convention Center
1:30
- 2:00 PM EST
Description
Supported by: FUJIFILM Healthcare Americas Corporation
CC surveillance is associated with reduced HCC mortality. However, ultrasound has insufficient sensitivity for early tumor detection, prompting increasing interest in blood-based biomarkers. In this session, we will review the phases of biomarker validation, present the status and data for (protein and liquid biopsy) biomarkers, and discuss ongoing biomarker studies.
Moderator:
Laura M. Kulik, MD
Presenters:
Professor Amit Singal, MD, MS
Professor Neehar Parikh, MD, MS